ZA201603117B - Withanolides useful for the treatment of neurodegenerative diseases - Google Patents
Withanolides useful for the treatment of neurodegenerative diseasesInfo
- Publication number
- ZA201603117B ZA201603117B ZA2016/03117A ZA201603117A ZA201603117B ZA 201603117 B ZA201603117 B ZA 201603117B ZA 2016/03117 A ZA2016/03117 A ZA 2016/03117A ZA 201603117 A ZA201603117 A ZA 201603117A ZA 201603117 B ZA201603117 B ZA 201603117B
- Authority
- ZA
- South Africa
- Prior art keywords
- withanolides
- useful
- treatment
- neurodegenerative diseases
- neurodegenerative
- Prior art date
Links
- PQZVBIJEPVKNOZ-PCLZMVHQSA-N (2R)-2-[(1S)-1-hydroxy-1-[(5R,6R,8R,9S,10R,13S,14R,17S)-5,6,14,17-tetrahydroxy-10,13-dimethyl-1-oxo-6,7,8,9,11,12,15,16-octahydro-4H-cyclopenta[a]phenanthren-17-yl]ethyl]-4,5-dimethyl-2,3-dihydropyran-6-one Chemical class C1C(C)=C(C)C(=O)O[C@H]1[C@](C)(O)[C@@]1(O)[C@@]2(C)CC[C@@H]3[C@@]4(C)C(=O)C=CC[C@]4(O)[C@H](O)C[C@H]3[C@]2(O)CC1 PQZVBIJEPVKNOZ-PCLZMVHQSA-N 0.000 title 1
- JAVFSUSPBIUPLW-QEWGJZFKSA-N Withanolide Natural products O=C1[C@@H](C)[C@H](C)C[C@H]([C@@H](C)[C@@H]2[C@@]3(C)[C@H]([C@@H]4[C@@H]([C@]5(C)[C@@H](CC4)CCCC5)CC3)CC2)O1 JAVFSUSPBIUPLW-QEWGJZFKSA-N 0.000 title 1
- 230000004770 neurodegeneration Effects 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361908455P | 2013-11-25 | 2013-11-25 | |
| PCT/US2014/067436 WO2015077780A1 (en) | 2013-11-25 | 2014-11-25 | Withanolides useful for the treatment of neurodegenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201603117B true ZA201603117B (en) | 2020-05-27 |
Family
ID=52023694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2016/03117A ZA201603117B (en) | 2013-11-25 | 2016-05-10 | Withanolides useful for the treatment of neurodegenerative diseases |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10351590B2 (enExample) |
| EP (1) | EP3074414B1 (enExample) |
| JP (1) | JP6517833B2 (enExample) |
| KR (1) | KR20160137945A (enExample) |
| CN (1) | CN105940010B (enExample) |
| AU (1) | AU2014352629B2 (enExample) |
| BR (1) | BR112016012002A2 (enExample) |
| CA (1) | CA2931064C (enExample) |
| ES (1) | ES2728870T3 (enExample) |
| MX (1) | MX364528B (enExample) |
| PL (1) | PL3074414T3 (enExample) |
| TR (1) | TR201905218T4 (enExample) |
| WO (1) | WO2015077780A1 (enExample) |
| ZA (1) | ZA201603117B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210087222A1 (en) * | 2017-12-11 | 2021-03-25 | Ethnodyne | Compounds for treating neurodegenerative disorders |
| EP3724170B1 (en) | 2017-12-11 | 2022-04-27 | Ethnodyne | Compounds for treating neurodegenerative disorders |
| EP3724207A1 (en) * | 2017-12-11 | 2020-10-21 | Ethnodyne | Compounds for treating neurodegenerative disorders |
| CN111377994A (zh) * | 2018-12-28 | 2020-07-07 | 南开大学 | 七种来源于灯笼果的醉茄内酯类化合物及其制备方法和用途 |
| CN116063373B (zh) * | 2023-02-14 | 2025-04-15 | 广西医科大学 | 天然产物27-Deoxywithaferin A的制备方法 |
| TW202521103A (zh) * | 2023-10-03 | 2025-06-01 | 美商恩維達醫療公司 | 醉茄素a（withaferin a）類似物及使用彼之治療方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010030395A2 (en) | 2008-09-15 | 2010-03-18 | Whitehead Institute For Biomedical Research | Withaferin a analogs and uses thereof |
| WO2010053655A2 (en) * | 2008-11-07 | 2010-05-14 | University Of Kansas | Therapeutic methods with withaferin a and analogs |
| WO2012106393A2 (en) * | 2011-02-01 | 2012-08-09 | University Of Kansas | Withanolide isolated from physalis longifolia and analogs and methods of use thereof |
| EP2723866B1 (en) | 2011-06-22 | 2018-03-28 | Universite Laval | Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease |
-
2014
- 2014-11-25 AU AU2014352629A patent/AU2014352629B2/en not_active Ceased
- 2014-11-25 US US15/038,927 patent/US10351590B2/en active Active
- 2014-11-25 EP EP14812105.6A patent/EP3074414B1/en active Active
- 2014-11-25 WO PCT/US2014/067436 patent/WO2015077780A1/en not_active Ceased
- 2014-11-25 ES ES14812105T patent/ES2728870T3/es active Active
- 2014-11-25 TR TR2019/05218T patent/TR201905218T4/tr unknown
- 2014-11-25 KR KR1020167015115A patent/KR20160137945A/ko not_active Ceased
- 2014-11-25 JP JP2016554830A patent/JP6517833B2/ja active Active
- 2014-11-25 CA CA2931064A patent/CA2931064C/en active Active
- 2014-11-25 PL PL14812105T patent/PL3074414T3/pl unknown
- 2014-11-25 BR BR112016012002A patent/BR112016012002A2/pt not_active IP Right Cessation
- 2014-11-25 CN CN201480064227.0A patent/CN105940010B/zh not_active Expired - Fee Related
- 2014-11-25 MX MX2016006544A patent/MX364528B/es active IP Right Grant
-
2016
- 2016-05-10 ZA ZA2016/03117A patent/ZA201603117B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2728870T3 (es) | 2019-10-29 |
| JP2016537432A (ja) | 2016-12-01 |
| BR112016012002A2 (pt) | 2017-09-19 |
| CN105940010A (zh) | 2016-09-14 |
| AU2014352629A1 (en) | 2016-05-26 |
| CA2931064A1 (en) | 2015-05-28 |
| CA2931064C (en) | 2022-10-18 |
| MX364528B (es) | 2019-04-30 |
| EP3074414B1 (en) | 2019-01-09 |
| MX2016006544A (es) | 2016-12-12 |
| WO2015077780A1 (en) | 2015-05-28 |
| CN105940010B (zh) | 2018-03-30 |
| US10351590B2 (en) | 2019-07-16 |
| EP3074414A1 (en) | 2016-10-05 |
| PL3074414T3 (pl) | 2019-12-31 |
| AU2014352629B2 (en) | 2019-03-28 |
| JP6517833B2 (ja) | 2019-05-22 |
| US20170022247A1 (en) | 2017-01-26 |
| KR20160137945A (ko) | 2016-12-02 |
| TR201905218T4 (tr) | 2019-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273815B (en) | Secondary vaccine particles for the treatment of inflammation | |
| IL287516A (en) | Medicinal uses of empagliflozin | |
| IL243976A0 (en) | kdm1a inhibitors for disease treatment | |
| IL239368A0 (en) | Sparing–ppar thiazolidinediones and combinations for the treatment of neurodegenerative diseases of the nervous system | |
| IL241264A0 (en) | Compounds and compositions for the treatment of parasitic diseases | |
| IL241101A0 (en) | Medicinal uses of empagliflozin | |
| IL244014A0 (en) | Combined therapy for the treatment of glioblastoma | |
| IL241102B (en) | Medicinal uses of empagliflozin | |
| SG11201509012QA (en) | Sobetirome in the treatment of myelination diseases | |
| PL2981271T3 (pl) | Zastosowania terapeutyczne empagliflozyny | |
| EP2906583A4 (en) | PEPTIDES FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES | |
| PL3062790T3 (pl) | Połączenia farmaceutyczne do leczenia raka | |
| ZA201603117B (en) | Withanolides useful for the treatment of neurodegenerative diseases | |
| EP3013824B8 (en) | Carboline compounds usable in the treatment of neurodegenerative diseases | |
| ZA201507718B (en) | The local treatment of inflammatory ophthalmic diseases | |
| IL243637A0 (en) | PPAR-sparing compounds for the treatment of metabolic diseases | |
| EP3089984A4 (en) | NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES | |
| IL234796B (en) | Compounds for the treatment of diseases related to ischemia-reperfusion | |
| HK40097140A (zh) | 治疗线粒体疾病的方法 | |
| PL3016948T3 (pl) | 2-acyloaminotiazole do leczenia nowotworów | |
| HK40032828A (en) | Methods for the treatment of mitochondrial disease | |
| HK40009827B (en) | Immune-modifying particles for the treatment of inflammation | |
| GB201306413D0 (en) | The local treatment of ophthalmic diseases | |
| GB201321628D0 (en) | Treatment of disease | |
| AU2013904239A0 (en) | Pharmaceutical combinations for the treatment of cancer |